Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Biomarin Pharmaceutical Inc (BMRN)  
$88.63 1.44 (1.6%) as of 4:30 Fri 4/19


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 188,370,000
Market Cap: 16.70(B)
Last Volume: 1,778,607 Avg Vol: 1,398,026
52 Week Range: $76.22 - $99
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  811
Guru Rank Value     : 0.9
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   BioMarin Pharmaceutical is a biotechnology company that develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Co.'s commercial products are Aldurazyme (laronidase) for Mucopolysaccharidosis I; Brineura (cerliponase alfa) for the treatment of late infantile neuronal ceroid lipofuscinosis type 2; Kuvan (sapropterin dihydrochloride) for the treatment of phenylketonuria; Naglazyme (galsulfase) the treatment of Mucopolysaccharidosis VI ; Palynziq (pegvaliase-pqpz) for adult patients with phenylketonuria; and Vimizim (elosulfase alpha) for the treatment of Mucopolysaccharidosis IV Type A.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 3,625
Total Buy Value $0 $0 $0 $314,469
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 156,079 229,843 273,203 611,547
Total Sell Value $13,472,349 $20,340,408 $24,241,430 $58,103,504
Total People Sold 5 5 6 7
Total Sell Transactions 13 19 25 55
End Date 2024-02-18 2023-11-17 2023-05-19 2022-05-19

   
Records found: 2560
  Page 20 of 103  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2019-05-10 4 AS $82.52 $825,193 D/D (10,000) 326,520     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2019-05-10 4 OE $14.39 $143,900 D/D 10,000 336,520     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2019-05-09 4 AS $81.97 $327,888 D/D (4,000) 326,520     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2019-05-09 4 OE $14.39 $57,560 D/D 4,000 330,520     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2019-05-08 4 AS $82.16 $328,625 D/D (4,000) 326,520     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2019-05-08 4 OE $14.39 $57,560 D/D 4,000 330,520     -
   Baffi Robert President, Global Mfg/Tech Ops   •       –      –    2019-04-30 4 A $68.78 $21,254 D/D 309 107,727     -
   Spiegelman Daniel K EVP, Chief Financial Officer   •       –      –    2019-04-30 4 A $68.78 $12,106 D/D 176 47,686     -
   Fuchs Henry J President, Worldwide R&D   •       –      –    2019-04-30 4 A $68.78 $21,254 D/D 309 124,845     -
   Mueller Brian SVP, Finance and CAO   •       –      –    2019-04-30 4 A $68.78 $20,566 D/D 299 13,959     -
   Davis George Eric EVP, General Counsel   •       –      –    2019-04-30 4 A $68.78 $21,254 D/D 309 72,199     -
   Ajer Jeffrey Robert EVP, Chief Commercial Officer   •       –      –    2019-04-30 4 A $68.78 $21,254 D/D 309 61,994     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2019-04-30 4 A $68.78 $21,254 D/D 309 326,520     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2019-04-26 4 AS $82.44 $248,640 D/D (3,000) 326,211     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2019-04-26 4 OE $14.39 $43,170 D/D 3,000 329,211     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2019-04-16 4 OE $21.51 $21,510 D/D 1,000 326,211     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2019-04-12 4 AS $89.12 $356,480 D/D (4,000) 325,211     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2019-04-12 4 OE $14.39 $57,560 D/D 4,000 329,211     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2019-04-11 4 OE $14.39 $14,390 D/D 1,000 325,211     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2019-04-08 4 AS $91.27 $275,598 D/D (3,000) 324,211     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2019-04-08 4 OE $14.39 $43,170 D/D 3,000 327,211     -
   Mueller Brian SVP, Corporate Controller   •       –      –    2019-04-05 4 AS $94.00 $277,582 D/D (2,953) 13,660     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2019-04-05 4 AS $93.37 $280,114 D/D (3,000) 324,211     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2019-04-05 4 OE $14.39 $43,170 D/D 3,000 327,211     -
   Spiegelman Daniel K EVP, Chief Financial Officer   •       –      –    2019-04-01 4 AS $89.00 $1,199,097 D/D (13,473) 47,510     -
  2560 Records found
  Previous  20  21  22  23  24  25  26  27  28  29  Next   
  Page 20 of 103
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us